Sanford-Burnham Medical Research Institute

Award Value
Research Leadership 1: Robert Wechsler-Reya The role of neural stem cells in cerebellar development, regeneration and tumorigenesis $5,226,050
Research Training II: Mark Mercola Type III CIRM Stem Cell Research Training Program $2,856,693
Early Translational IV: Stuart Lipton Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke $2,124,000
Shared Labs: Evan Snyder Collaborative Laboratory for Human Embryonic Stem Cell Research $1,805,884
Disease Team Planning: Mark Mercola "Stem Cell Therapies for Heart Failure" $44,450
SEED Grant: Huei-sheng Chen Development of Neuro-Coupled Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells. $695,680
Comprehensive Grant: Mark Mercola Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes $2,832,000
SEED Grant: Robert Oshima Trophoblast differentiation of human ES cells. $696,354
SEED Grant: Hudson Freeze Role of Glycans in Human Embryonic Stem Cell Conversion to Neural Precursor Cells $708,000
SEED Grant: Gregg Duester Retinoic Acid-FGF Antagonism during Motor Neuron Differentiation of Human ES Cells $695,229
Basic Biology II: Huei-sheng Chen Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes $1,587,610
SEED Grant: Zhuohua Zhang Modeling Parkinson's Disease Using Human Embryonic Stem Cells $701,060
New Cell Lines: Zhuohua Zhang Derivation of Parkinson's Disease Coded-Stem Cells (PD-SCs) $1,556,448
SEED Grant: Ziwei Huang New Chemokine-Derived Therapeutics Targeting Stem Cell Migration $708,000
Disease Team Therapy Planning I: Stuart Lipton hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease $96,448
Comprehensive Grant: Stuart Lipton MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells $2,832,000
SEED Grant: Alexey Terskikh Analysis of Candidate Neural Crest Cells Derived from Human ES Cells $703,684
Disease Team Therapy Planning I: Marcel Daadi Neural Stem Cell-Based Therapy For Parkinson’s Disease $63,952
Early Translational I: Evan Snyder Developmental Candidates for Cell-Based Therapies for Parkinson's Disease (PD) $5,190,752
Basic Biology IV: Huei-sheng Chen Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells $1,582,606
Training Grant I-2: Mark Mercola Burnham Institute CIRM Stem Cell Training Grant (Type II) $1,061,865
Total:
$33,768,765.00
Icon for xls export